BBVA shareholders showed overwhelming support for all of the items proposed on the agenda at the 2025 Annual General Meeting, ...

LUXEMBOURG--(BUSINESS WIRE)--SES S.A. (“SES” or the “Company”) today issued the following statements in relation to the Company’s upcoming Annual General Meeting (“AGM”), taking ...

A Q1 Qualitative Update will be published on May 12, 2025. The 2025 Interim Report will be published on August 12, 2025.

At today's Annual General Meeting of BRAIN Biotech AG (Frankfurt Stock Exchange / BNN / ISIN DE0005203947 / WKN 5203949), shareholders approved all agenda items with a broad majority. Dr.

Zurich, 20 March 2025 – Cembra published the agenda items and proposals of the Board of Directors for the Annual General Meeting today. The Annual General Meeting 2025 will take place on Thursday, 24 ...

SES S.A. (“SES” or the “Company”) today issued the following statements in relation to the Company’s upcoming Annual General Meeting (“AGM”), taking place on 3 April 2025: The Company is pleased to ...

today published the agenda of the Annual General Meeting on April 10, 2025. Karen Huebscher, who has served as a member of the Board of Directors since 2012, has decided not to stand for re-election.